Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member
 Audit CommitteeCompensation CommitteeNominating and Corporate Governance Committee
Mohammad Azab, M.B. ChB., MBA 
Mohammad Azab, M.B. ChB., MBA

Dr. Azab has served as a member of our Board since October 2003. In July 2009, Dr. Azab joined Astex Pharmaceuticals, Inc., a pharmaceutical company focused on the discovery and development of drugs in oncology and other areas, as its Chief Medical Officer. Since January 2014, Dr. Azab has served as President and Chief Medical Officer of Astex and has been a member of Astex’s Board of Directors. Previously, Dr. Azab served as President and CEO of Intradigm Corporation, a privately held Palo Alto... 
  Chairperson  
Steven Gannon, CA 
Steven Gannon, CA

Mr. Gannon has served as a member of our Board since May 2015. Mr. Gannon has also served on the Board of Directors of Advanced Accelerator Applications SA, a publicly-traded biotechnology company, since June 2014. Mr. Gannon was Chief Financial Officer, Senior Vice President of Finance and Treasurer at Aptalis Pharma Inc. until February 2014, after which it was sold to Forest Laboratories. Prior to joining Aptalis Pharma Inc. in 2006, Mr. Gannon served as the Chief Financial Officer for Cryocat... 
Committee Member   
Frank Holler, MBA 
Frank Holler, MBA

Mr. Holler has served as a member of our Board since March 1999. Mr. Holler previously served as Xenon’s President and CEO from 1999 to 2003. Mr. Holler currently serves as director and chairman of Sernova Corporation, a publicly-traded biotechnology company. Mr. Holler previously served as chairman and CEO at BC Advantage Funds (VCC) Ltd., a venture capital firm and publicly-traded company that invested in emerging life science, clean tech and information technology companies. Mr. Holler also p... 
Chairperson   
Gary Patou, MD 
Gary Patou, MD

Dr. Patou has served as a member of our Board since January 2004. Dr. Patou has been a Managing Director at MPM Capital, a venture capital fund focused on life sciences companies, since 2005, and has served as interim Chief Medical Officer in various MPM portfolio companies. Currently, Dr. Patou is Chief Medical Officer at True North Therapeutics, Inc. and is a senior medical advisor to Chiasma, Inc. Dr. Patou previously served as Chief Medical Officer for Pacira Pharmaceuticals, Inc., a special... 
  Committee Member Chairperson
Richard Scheller, PhD 
Richard Scheller, PhD

Dr. Scheller has served as a member of our Board since March 2015. Dr. Scheller has been Chief Science Officer at 23andMe, a personal genetics company, since 2015. Previously, Dr. Scheller was the Executive Vice President of Research and Early Development and a member of the Executive Committee at Genentech, Inc. from February 2001 to December 2014. From January 2009 to December 2014, Dr. Scheller was also a member of the Enlarged Executive Committee at Hoffmann-La Roche Ltd. Since February 2015... 
  Committee Member  
Dawn Svoronos 
Dawn Svoronos

Ms. Svoronos has served as a member of our Board since September 2016. Ms. Svoronos sits on the board of directors of PTC Therapeutics, a publicly-traded biopharmaceutical company, and is currently chair of the board for Theratechnologies Inc., a publicly-traded biopharmaceutical company. Ms. Svoronos retired in 2011 from Merck & Co. following a 23-year career in commercial positions of increasing seniority, most recently as President of Europe and Canada. In that role, Ms. Svoronos had full P&L... 
   Committee Member
Michael Tarnow, JD 
Michael Tarnow, JD

Mr. Tarnow has served as a member of our Board since March 1999. Since 1995, Mr. Tarnow has been an advisor to and member of the boards of directors of private and public healthcare and biotechnology companies in the U.S., Canada and Europe, including Axcan Pharma, Creative Biomolecules, Inc., Caprion Pharmaceuticals Inc. and MediGene AG. He served as chair of EntreMed, Inc. (now CASI Pharmaceuticals, Inc.) a publicly-traded biotechnology company, from February 2003 to February 2009, and served ... 
Committee Member   Committee Member